Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Circ Heart Fail. 2018 Feb;11(2):e004000. doi: 10.1161/CIRCHEARTFAILURE.117.004000

Table 2.

Factors associated with survival in ATTRwt (n = 101)

Variable Univariate analysis Hazard Ratio (95% CI) P Multivariate analysis Hazard Ratio (95% CI) P
TTR (mg/dL) 0.93 (0.88 – 0.98) 0.007 0.89 (0.84 – 0.95) < 0.001
cTn-I (ng/mL) 5.12 (2.43 – 10.81) < 0.001 8.06 (3.01 – 21.57) < 0.001
BNP (pg/mL) 1.001 (1.001 – 1.002) 0.002
LVEF (%) 0.96 (0.94 – 0.99) 0.001 0.97 (0.94 – 0.99) 0.01
Creatinine (mg/dL) 2.02 (1.14 – 3.60) 0.02
Uric acid (mg/dL) 1.14 (1.02 – 1.28) 0.02
Sedimentation rate (mm/hr) 1.03 (1.01 – 1.04) 0.001

ATTRwt indicates wild-type transthyretin amyloidosis; TTR, transthyretin; cTn-I, cardiac troponin I; BNP, B-type natriuretic peptide; LVEF, left ventricular ejection fraction; and CI, confidence interval

HHS Vulnerability Disclosure